Dr Reddys Laboratories (RDY) Short-term Investments (2018 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Short-term Investments of $2.0 million for Q1 2026, down 71.43% year-over-year from $7.0 million in Q1 2025, and down 71.43% quarter-over-quarter from $7.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Short-term Investments (2018 - 2026) Analysis & Trends
Dr Reddys Laboratories' Short-term Investments history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 71.43% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 71.43% YoY), while the FY2026 annual figure was $2.0 million, down 71.43% from the prior year.
- Short-term Investments for Q1 2026 stood at $2.0 million, down from $7.0 million in the prior quarter.
- The five-year high for Short-term Investments was $389.0 million in Q1 2022, with the low at $2.0 million in Q1 2024.
- The 5-year median for Short-term Investments is $7.0 million (2025), against an average of $83.0 million.
- The sharpest annual moves came in 2022 and 2023: Short-term Investments soared 2188.24% in 2022, then sank 96.14% in 2023.
- Dr Reddys Laboratories' Short-term Investments stood at $389.0 million in 2022, then sank by 96.14% to $15.0 million in 2023, then slumped by 86.67% to $2.0 million in 2024, then jumped by 250.0% to $7.0 million in 2025, then sank by 71.43% to $2.0 million in 2026.
- Business Quant data shows RDY's Short-term Investments at $2.0 million in Q1 2026, $7.0 million in Q1 2025, and $2.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Mar 31, 2022 | 389.00 Mn |
| Mar 31, 2021 | 17.00 Mn |
| Mar 31, 2020 | 314.00 Mn |
| Mar 31, 2019 | 5.00 Mn |
| Mar 31, 2018 | 2.00 Mn |